Site Registration
Registration benefits include:
- Access to CME/CE programs
- Free subscription to Current Medical Evidence
- Reminders of new CME/CE activities
About This Section
Ask the Expert, one of the interactive osteoporosis education features offered on OsteoporosisTX.com, provides you the opportunity to direct questions to our expert panel of clinicians about osteoporosis treatment and prevention. Our panel will address questions across a range of clinical topics relating to bone loss and osteoporosis, including risk assessment, diagnosis, bone density monitoring, fracture prevention, osteoporosis therapy, safety issues, and the role of bisphosphonates, calcitonin, estrogen/hormone therapy, estrogen receptor agonists/antagonists, PTH analogs, and other agents in osteoporosis treatment.
Questions submitted to Ask the Expert and the answers provided by the members of our panel will be posted on OsteoporosisTX.com along with supporting literature where appropriate.
Guidance for men undergoing androgen deprivation therapy
Release date: August 2009
Expiration date: August 31, 2010
Estimated time to complete activity: 15 minutes
Sponsored by
Support for this activity has been provided through an educational donation from
Activity Overview
Questions submitted to Ask the Expert and the answers provided by the members of our panel will be posted on OsteoporosisTX.com along with supporting literature where appropriate.
Participants are required to read each of the following Ask the Expert questions to receive 0.25 AMA PRA Category 1 Credit™:
Target Audience
This activity has been developed to meet the current educational needs of physicians and other health care professionals in endocrinology, rheumatology, obstetrics/gynecology, and primary care who manage patients who have or are at risk for osteoporosis.
Learning Objectives
Each Ask the Expert activity will have one or more of the following learning objectives associated with it.
Upon completion of this activity, participants should be able to:
- Evaluate the risk for osteoporosis and osteoporosis-related fractures in patients, including the consideration of secondary osteoporosis
- Identify considerations for patient management such as who to treat, duration of therapy, and combination therapy
- Assess the risk/benefit ratio of currently available treatment options for osteoporosis
Faculty
Listed below is the faculty panel for the Ask the Expert section of OsteoporosisTX.com. One faculty member has been selected to answer this Ask the Expert question based on his or her area of expertise.
Felicia Cosman, MD
Professor of Clinical Medicine
Columbia University College of Physicians and Surgeons
New York, New York
Medical Director, Clinical Research Center
Helen Hayes Hospital
West Haverstraw, New York
Jeffrey P. Levine, MD, MPH
Associate Professor
Departments of Family Medicine and Obstetrics, Gynecology & Reproductive Sciences
Director of Women’s Health Programs, Department of Family Medicine
Master Educators Guild
UMDNJ–Robert Wood Johnson Medical School
New Brunswick, New Jersey
Michael J. Maricic, MD
Clinical Associate Professor of Medicine
University of Arizona School of Medicine
Co-Director, Clinical Research
Catalina Pointe Rheumatology
Tucson, Arizona
Accreditation Statement
Curatio CME Institute is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
Credit Designation
Curatio CME Institute designates this educational activity for a maximum of 0.25 AMA PRA Category 1 Credit™. Physicians should only claim credit commensurate with the extent of their participation in the activity.
Method of Participation
There are no fees for participating in this CME activity. To receive credit during the period August 2009 to August 31, 2010, participants must (1) read the learning objectives and disclosure statements, (2) study the three questions outlined in the Activity Overview, and (3) complete the activity evaluation form, including the participation attestation statement.
Media
The Internet was selected as the instructional format to accommodate the learning preferences of a significant portion of the target audience.
Disclosure
In accordance with the ACCME Standards for Commercial Support, all CME providers are required to disclose to the activity audience the relevant financial relationships of everyone in a position to control content of an educational activity. A relevant financial relationship is a relationship in any amount occurring in the last 12 months with a commercial interest whose products or services are discussed in the CME activity content over which the individual has control. Relationship information appears below:
Felicia Cosman, MD, has disclosed the following relevant financial relationship(s):
| Advisory Board | Amgen, Lilly, Merck, Novartis |
| Consultant | Amgen, Merck, Novartis, Pfizer |
| Speaker | Lilly, Merck, Novartis |
Dr. Cosman may discuss the unlabeled or investigational use of a commercial product.
Jeffrey P. Levine, MD, MPH, has disclosed the following relevant financial relationship(s):
| Consultant | Novartis, Wyeth |
Dr. Levine may discuss the unlabeled or investigational use of a commercial product.
Michael J. Maricic, MD, has disclosed the following relevant financial relationship(s):
| Advisor, Grants, Research, Speaker | Amgen, Lilly, Merck, Novartis, Procter & Gamble, Roche |
Dr. Maricic may discuss the unlabeled or investigational use of a commercial product.
Curatio CME Institute
Shari Dermer, PhD, Director, Scientific Services, has disclosed no relevant financial relationships.
Jonathan S. Simmons, ELS, Managing Editor, has disclosed no relevant financial relationships.
Derek Warnick, CME Director, has disclosed no relevant financial relationships.
Disclaimer
The information presented in this activity is for continuing medical education purposes only and is not meant to substitute for the independent medical judgment of a physician regarding diagnosis and treatment of a specific patient's medical condition.
Unapproved Product Use
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the US Food and Drug Administration. Curatio CME Institute and Amgen do not recommend the use of any agent outside the labeled indications.
The opinions expressed in this educational activity are those of the faculty and do not necessarily represent the views of Curatio CME Institute or Amgen. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
OsteoporosisTX.com is owned and operated by Curatio CME Institute with content expertise provided by the National Osteoporosis Foundation.
Hardware/Software Requirements
- Version 5.0 or higher for Microsoft Internet Explorer or Netscape 6 or higher
- If you are using a Mac computer system and are experiencing problems with your browser, we suggest downloading the latest version of Firefox for Mac
Contact Information
OsteoporosisTX.com
100 Campbell Boulevard
Suite 103
Exton, PA 19341
OsteoporosisTX@curatiocme.com
Policy on Privacy and Confidentiality
Curatio CME Institute makes every effort to protect the privacy of OsteoporosisTX.com users; user information is used only to maintain records as required by the American Medical Association (AMA) and the ACCME.
Curatio CME Institute does not require individuals to register to use OsteoporosisTX.com; registration is only required for physicians, health care professionals, and other users to participate in and receive CME/CE credit for accredited educational programs hosted on OsteoporosisTX.com.
Curatio CME Institute is required by the AMA and the ACCME (and occasionally by other accrediting organizations) to collect user information that will allow Curatio CME Institute to issue a CME/CE certificate. Curatio CME Institute is required to keep this information on file for up to 6 years. The information is stored in a secure database and used only to verify individual participation in a CME/CE activity and to reissue a certificate if a user's original certificate is lost or misplaced.
Information gathered through OsteoporosisTX.com will not be released to any other company or organization for any purpose; this information remains confidential. At the end of the mandatory 6-year period, these records will be destroyed.
Curatio CME Institute uses Web site tracking software to determine how OsteoporosisTX.com is used. This information helps Curatio CME Institute determine the best strategies for improving OsteoporosisTX.com and better meeting the needs of its users. This software does not identify individual users.
OsteoporosisTX.com does not employ cookies or any other software that violates a user's privacy.
If you have any questions about OsteoporosisTX.com or any Curatio CME Institute policies, you may contact us at OsteoporosisTX@curatiocme.com.
Thank you for using OsteoporosisTX.com.
